Moneycontrol
Get App
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Ipca Laboratories

Ipca Laboratories

BSE: 524494|NSE: IPCALAB|ISIN: INE571A01020|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Apr 07, 16:00
1524.15
139.3 (10.06%)
VOLUME 104,684
LIVE
NSE
Apr 07, 15:59
1526.15
140.6 (10.15%)
VOLUME 2,379,565
News on Ipca Laboratories
Select Year: 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
ICMR recommends use of anti-malaria drug hydroxychloriquine for treating high-risk COVID-19 patients

6.27 pm | 23 Mar 2020 |  Source: Moneycontrol.com

The high risk population who would be eligible for getting the drug include asymptomatic healthcare workers involved in the care of suspected or confi...

Ipca Labs share price surges 12% as USFDA partially lifts import ban for chloroquine

9.56 am | 23 Mar 2020 |  Source: Moneycontrol.com

The stock gained over 62 percent in the last 6 months and was trading with volumes of 19,120 shares...

Buy Ipca Laboratories; target of Rs 1826: Prabhudas Lilladher

12.08 pm | 20 Feb 2020 |  Source: Moneycontrol.com

Prabhudas Lilladher is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 1826 in its research report date...

Buy Ipca Laboratories target of Rs 1590: Sharekhan

3.36 pm | 14 Feb 2020 |  Source: Moneycontrol.com

Sharekhan is bullish on Ipca Laboratories has recommended buy rating on the stock with a target price of Rs 1590 in its research report dated February...

Ipca Labs Consolidated December 2019 Net Sales at Rs 1,212.86 crore, up 20.55% Y-o-Y

3.00 pm | 14 Feb 2020 |  Source: Moneycontrol.com

NULL...

1 2
Quick Links for Ipca Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.